Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Januar 2021

Planlagt Fastgjort Låst Flyttet Genmab
1.5k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • E Offline
    E Offline
    E_L
    wrote on sidst redigeret af
    #273

    small new The DART Study- Daratumumab Treatment in ITP https://clinicaltrials.gov/ct2/show/NCT04703621

    1 Reply Last reply
    0
    • K Offline
      K Offline
      Klarussen
      wrote on sidst redigeret af
      #274

      Ja ja, vi snuste da til ATH 2579

      1 Reply Last reply
      0
      • Helge_LarsenPI-redaktørH Offline
        Helge_LarsenPI-redaktørH Offline
        Helge_LarsenPI-redaktør
        wrote on sidst redigeret af
        #275

        Genmab
        @Genmab
        ·
        2 t
        Don’t miss us at #JPM21 on Jan 13 at 10 AM ET/ 4 PM CET! We’ll be discussing highlights of our #oncology research, innovative pipeline and priorities for 2021. https://jpmorgan.metameetings.net/events/healthc

        1 Reply Last reply
        0
        • royalR Offline
          royalR Offline
          royal
          wrote on sidst redigeret af
          #276

          Link virker ikke.

          1 Reply Last reply
          0
          • Helge_LarsenPI-redaktørH Offline
            Helge_LarsenPI-redaktørH Offline
            Helge_LarsenPI-redaktør
            wrote on sidst redigeret af
            #277

            Det her er vist bedre: https://jpmorgan.metameetings.net/events/healthcare21/general_signin

            1 Reply Last reply
            0
            • royalR Offline
              royalR Offline
              royal
              wrote on sidst redigeret af
              #278

              Tak 🙂

              1 Reply Last reply
              0
              • royalR Offline
                royalR Offline
                royal
                wrote on sidst redigeret af
                #279

                Fik dog ikke noget ud af det.....

                1 Reply Last reply
                0
                • royalR Offline
                  royalR Offline
                  royal
                  wrote on sidst redigeret af
                  #280

                  The agenda is made available only to confirm
                  ed attendees.

                  1 Reply Last reply
                  0
                  • royalR Offline
                    royalR Offline
                    royal
                    wrote on sidst redigeret af
                    #281

                    Link Preview Image
                    Healthcare Conference

                    favicon

                    (www.jpmorgan.com)

                    1 Reply Last reply
                    0
                    • S Offline
                      S Offline
                      Sukkeralf
                      wrote on sidst redigeret af
                      #282

                      Stadig gang i checkpoint deals

                      1 Reply Last reply
                      0
                      • S Offline
                        S Offline
                        Sukkeralf
                        wrote on sidst redigeret af
                        #283

                        Just a moment...

                        favicon

                        (www.firstwordpharma.com)

                        1 Reply Last reply
                        0
                        • Helge_LarsenPI-redaktørH Offline
                          Helge_LarsenPI-redaktørH Offline
                          Helge_LarsenPI-redaktør
                          wrote on sidst redigeret af
                          #284

                          God morgen. 🙂

                          1 Reply Last reply
                          0
                          • Helge_LarsenPI-redaktørH Offline
                            Helge_LarsenPI-redaktørH Offline
                            Helge_LarsenPI-redaktør
                            wrote on sidst redigeret af
                            #285

                            Tirsdagens danske avisuddrag med DI, Vaccinepas og Coloplasthttps://www.proinvestor.com/investornyt/671005/tirsdagens-danske-avisuddrag-med-di-vaccinepas-og-coloplast

                            1 Reply Last reply
                            0
                            • E Offline
                              E Offline
                              E_L
                              wrote on sidst redigeret af
                              #286

                              Johnson & Johnson (JNJ) CEO Alex Gorsky Presents at 39th Annual JPMorgan Virtual Healthcare Conference (Transcript) https://seekingalpha.com/article/4398411-johnson-johnson-jnj-ceo-alex-gorsky-presents-39th-annual-jpmorgan-virtual-healthcare

                              1 Reply Last reply
                              0
                              • S Offline
                                S Offline
                                Sukkeralf
                                wrote on sidst redigeret af
                                #287

                                Next is about the pipeline that we have. More than 10 compounds that we expect to file or launch over the next several years, all of which have more than a $1 billion worth of potential. These are really exciting areas certainly in areas such as oncology. For example the CD3s, both the CD3 and BCMA CD3 that we have and things like multiple myeloma. If you look at what we have in immunology, of course, the recent addition of Momenta, we're very excited about that as well.

                                1 Reply Last reply
                                0
                                • S Offline
                                  S Offline
                                  Sukkeralf
                                  wrote on sidst redigeret af
                                  #288

                                  Just maybe double down on what Alex says, there are some very excited – exciting assets in the pipeline that we have just recently filed are in the process of being filed I think of amivantamab for small cell lung cancer. We filed that I think was early December for monotherapy. We look to combine that with lazertinib to have a bigger impact in non-small cell lung cancer.

                                  1 Reply Last reply
                                  0
                                  • G Offline
                                    G Offline
                                    GeorgeBest
                                    wrote on sidst redigeret af
                                    #289

                                    Refinitiv Eikon screenshot: News: NCC to develop and build new headquarters for Genmab at Kontorværket in Copenhagen - CIS | News Wires | Refinitiv Eikon

                                    1 Reply Last reply
                                    0
                                    • E Offline
                                      E Offline
                                      E_L
                                      wrote on sidst redigeret af
                                      #290

                                      Halozyme Provides 2021 Financial Guidance https://www.halozyme.com/investors/news-releases/news-release-details/2021/Halozyme-Provides-2021-Financial-Guidance-Highlighted-By-Strong-Revenue-And-EPS-Growth/default.aspx

                                      1 Reply Last reply
                                      0
                                      • P Offline
                                        P Offline
                                        Plimsoller
                                        wrote on sidst redigeret af
                                        #291

                                        Valby er jo også STEDET ifølge en Olsen Banden film 🙂

                                        1 Reply Last reply
                                        0
                                        • P Offline
                                          P Offline
                                          Plimsoller
                                          wrote on sidst redigeret af
                                          #292

                                          Link Preview Image
                                          Genmab flytter til Valby i 2023: Nyt domicil giver plads til vækst

                                          Medicinalvirksomheden Genmab rykker i 2023 fra Kalvebod Brygge i København og ind i nye hovedkontorfaciliteter i Valby, som NCC har designet og til april går i gang med at opføre. Det fremgår af en me

                                          favicon

                                          borsen.dk (borsen.dk)

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger